Literature DB >> 16280612

Wound botulism in injectors of drugs: upsurge in cases in England during 2004.

D Akbulut1, J Dennis, M Gent, K A Grant, V Hope, C Ohai, J McLauchlin, V Mithani, O Mpamugo, F Ncube, L de Souza-Thomas.   

Abstract

Wound infections due to Clostridium botulinum were not recognised in the UK and Republic of Ireland before 2000. C. botulinum produces a potent neurotoxin which can cause paralysis and death. In 2000 and 2001, ten cases were clinically recognised, with a further 23 in 2002, 15 in 2003 and 40 cases in 2004. All cases occurred in heroin injectors. Seventy cases occurred in England; the remainder occurred in Scotland (12 cases), Wales (2 cases) and the Republic of Ireland (4 cases). Overall, 40 (45%) of the 88 cases were laboratory confirmed by the detection of botulinum neurotoxin in serum, or by the isolation of C. botulinum from wounds. Of the 40 cases in 2004, 36 occurred in England, and of the 12 that were laboratory confirmed, 10 were due to type A. There was some geographical clustering of the cases during 2004, with most cases occurring in London and in the Yorkshire and Humberside region of northeast England.

Entities:  

Mesh:

Year:  2005        PMID: 16280612

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  12 in total

1.  Wound botulism in drug users: a still underestimated diagnosis.

Authors:  C Rodolico; E Barca; L Fenicia; F Anniballi; A U Sinardi; P Girlanda
Journal:  Neurol Sci       Date:  2010-06-15       Impact factor: 3.307

2.  Diagnostic pitfall: wound botulism in an intoxicated intravenous drug abuser presenting with respiratory failure.

Authors:  Georg Royl; Juri Katchanov; Frank Stachulski; Jörg Schultze; Christoph J Ploner; Matthias Endres
Journal:  Intensive Care Med       Date:  2007-03-29       Impact factor: 17.440

3.  Complete genome sequence of the proteolytic Clostridium botulinum type A5 (B3') strain H04402 065.

Authors:  Andrew T Carter; Bruce M Pearson; Lisa C Crossman; Nizar Drou; Darren Heavens; David Baker; Melanie Febrer; Mario Caccamo; Kathie A Grant; Michael W Peck
Journal:  J Bacteriol       Date:  2011-03-04       Impact factor: 3.490

Review 4.  Tetanus in animals.

Authors:  Michel R Popoff
Journal:  J Vet Diagn Invest       Date:  2020-02-18       Impact factor: 1.279

5.  Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin.

Authors:  Norbert Galldiks; Silke Nolden-Hoverath; Christoph M Kosinski; Ulrike Stegelmeyer; Sylvia Schmidt; Christian Dohmen; Jens Kuhn; Kathrin Gerbershagen; Heiko Bewermeyer; Peter Walger; Rolf Biniek; Michael Neveling; Andreas H Jacobs; Walter F Haupt
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

6.  First case of type E wound botulism diagnosed using real-time PCR.

Authors:  Ingrid Artin; Per Björkman; Jonas Cronqvist; Peter Rådström; Elisabet Holst
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

7.  Universal and specific quantitative detection of botulinum neurotoxin genes.

Authors:  Brenna J Hill; Janet C Skerry; Theresa J Smith; Stephen S Arnon; Daniel C Douek
Journal:  BMC Microbiol       Date:  2010-10-20       Impact factor: 3.605

8.  Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study.

Authors:  Ivar Skeie; Mette Brekke; Morten Lindbaek; Helge Waal
Journal:  BMC Public Health       Date:  2008-01-31       Impact factor: 3.295

9.  Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.

Authors:  Vivian Hope; Jo Kimber; Peter Vickerman; Matthew Hickman; Fortune Ncube
Journal:  BMC Infect Dis       Date:  2008-09-18       Impact factor: 3.090

10.  Infections with spore-forming bacteria in persons who inject drugs, 2000-2009.

Authors:  Norah E Palmateer; Vivian D Hope; Kirsty Roy; Andrea Marongiu; Joanne M White; Kathie A Grant; Colin N Ramsay; David J Goldberg; Fortune Ncube
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.